NextCell Pharma AB
Developing pioneering cell therapies for autoimmune diseases and diabetes.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2014
- Grundlagt
Nøglebeslutningstagere
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
+8 flere kontakter i Funnelfeedr
Beskrivelse
NextCell Pharma AB is a Swedish biopharmaceutical company focused on revolutionizing treatment for severe and incurable diseases using cell therapies. The company operates three core business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). The...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556965836101
Beslutningstagere
12 kontakter i FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Edvard Smith
Medical Director
Lindsay Davies
Board Member
Sofia Sisay
Head of Clinical Trials
Hans-Peter Ekre
Chairman of the Board
Eva Sjökvist Saers
Board Member
Camilla Myhre Sandberg
Board member
Sofie Falk Jansson
CEO of Cellaviva
Andre kontakter
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Cellaviva AB
5–9 medarbejdereScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 medarbejdereSpecialist quality control analytics provider for cell and gene therapies.
Xintela AB
10–19 medarbejdereDeveloping stem cell and targeted cancer therapies for unmet needs.
Xbrane Biopharma AB
20–49 medarbejdereDeveloping cost-effective biosimilars using proprietary platform technology.
Swedish StromaBio AB
1 medarbejdereClinical stage biopharma developing MSC therapies for ARDS and Alzheimer's.
Udforsk mere
Spørgsmål om NextCell Pharma AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo